7Peters DH,Feiedel HA,Mctavish D.Aufltnntycm:a riview of its antimicrobid activity,pharmacokinetic properties and clinical efficacy[J].Drugs,1992,44:750.
8Glezen W P, Taber L H, Frank A L, et al. Risk of primary infection and reinfection with respiratory syneytial virus. Am J Dis Child, 1986, 140(6) :543 -546.
9Smith G P. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science, 1985, 228(4705) : 1315 - 1317.
10Ghildyal R, Ho A, Jans D A. Central role of the respiratory syncytial virus matrix protein in infection. FEMS Microbiol Rev, 2006, 30(5) : 692 -705.
